Cybin reports fiscal year 2025 financial results and recent business highlights

Toronto--(business wire)--cybin inc. (nyse american:cybn) (cboe canada ca:cybn) (“cybin” or the “company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today reported audited financial results for its fiscal year ended march 31, 2025, and recent business highlights. “during the past 12 months, we have continued to focus on building out the strong foundation that underpins.
CYBN Ratings Summary
CYBN Quant Ranking